Search results

  1. MSEsperanza

    The pervasive problem with placebos in psychology: Why active control groups are not sufficient..., 2013, Boot et al.

    Can't it also work vice versa? The transient effects make people believe that the placebo really works so they expect that they need just more of the treatment and that in turn makes them hopeful and let them revise the severity of their symptoms (even if they only experience repeated short term...
  2. MSEsperanza

    Clinical trial outcome measures of improvement and recovery in ME/CFS - which ones are useful? Discussion thread

    (Just leaving some thoughts here before I try to have a bit of a forum break. So apologies if this is somewhat out of context.) What perhaps also needs to be considered is how structural/ systemic bias can impact even objective outcomes. Health care usage, for instance. If doctors have nothing...
  3. MSEsperanza

    ...discrepancies between objective and subjective measurement of the physical activity level in female patients with [CFS], 2021, Vergauwen et al

    It would be interesting to see the full text and know in which way the relationship of objective and subjective measurements exactly differed in each group and between the groups. I have no reason to doubt the correctness of their conclusion: I'd like to know though whether there was a clear...
  4. MSEsperanza

    Trials on therapist-delivered treatments (for illnesses or symptoms that don't have biomarkers yet) that used objective outcomes as primary endpoints

    I'm afraid there are a few more examples of trials that applied objective outcomes, but the trial design is bad for other reasons:
  5. MSEsperanza

    Interventions that manipulate how patients report symptoms as a separate form of bias

    Perhaps one needs to differentiate the risk for bias in in interventions that aim at modifying how people perceive and thus report symptoms? 1) In health anxiety or depression, I think some of the symptoms actually are how patients perceive symptoms. It might still be difficult to...
  6. MSEsperanza

    Interventions that manipulate how patients report symptoms as a separate form of bias

    Or an acronym? IMPRESS bias (Interventions that aim at Modifying how Patients REport SymptomS) (not serious.) I still think it's not just 'one' bias -- it's an entire subdivision of clinicians' distorted perception of certain illnesses and symptoms that implies a complex of biases, including...
  7. MSEsperanza

    Interventions that manipulate how patients report symptoms as a separate form of bias

    Not sure whether this is actually needed. Clinical trials just should apply scales that are both truly validated and relevant for the illness. I think that there exist some good health anxiety and depression scales , but they are validated to measure symptoms of health anxiety and...
  8. MSEsperanza

    Trials on therapist-delivered treatments (for illnesses or symptoms that don't have biomarkers yet) that used objective outcomes as primary endpoints

    This Cochrane database on physical therapies could be helpful? (*) https://www.cochrane.de/sites/cochrane.de/files/public/uploads/gfb/final_cochrane_fur_die_pt_datenbank.xlsx And there's that poster by another group: Physical activity/exercise for health outcomes: an overview of Cochrane...
  9. MSEsperanza

    Nature - Chronic post-COVID-19 syndrome and chronic fatigue syndrome: Is there a role for extracorporeal apheresis?, 2021, Bornstein et al

    Indeed. Interesting co-authorship. From a quiick glance, nobody from the Scheibenbogen team involved, but in addition to the three staff members from the private clinic linked above, mostly affiliations with renowned universities, including two authors from the Institute of Psychiatry...
  10. MSEsperanza

    Nature - Chronic post-COVID-19 syndrome and chronic fatigue syndrome: Is there a role for extracorporeal apheresis?, 2021, Bornstein et al

    Edit: Three of the authors are affiliated with a private clinic in Germany: https://www.inusmedical.de/start-englisch/ https://www.inusmedical.de/inuspheresis-englisch/ :confused:
  11. MSEsperanza

    Active placebos versus antidepressants for depression, 2004, Moncrieff, Wessely, Hardy

    It's an updated review, the original is from 1998. So probably just a decadial typo... WHO knows?
  12. MSEsperanza

    Active placebos versus antidepressants for depression, 2004, Moncrieff, Wessely, Hardy

    But does he really? I don't have access to the review from here and so don't know if the authors explicitly discuss the issue with subjective measures. The only outcome mentioned in the abstract is "improvement in mood" -- that seems to be insufficent to measure symptoms of depression anyway...
  13. MSEsperanza

    Active placebos versus antidepressants for depression, 2004, Moncrieff, Wessely, Hardy

    Would be interesting to know if there is some sort of chronology in his conclusions from this and similar trials and the subject as well als trial design of following trials? I just began to re-read SW's national elf blog article on the PACE trial. In addition to the ocean liner rhetoric that...
  14. MSEsperanza

    Bias due to a lack of blinding: a discussion

    Another point that I don't have the expertise to understand is: Is it really possible to compensate / correct serious shortcomings in trial methodology with some additional statistical work? E.g., again from the example above: I think there are similar examples, also from Crawley and the...
  15. MSEsperanza

    Bias due to a lack of blinding: a discussion

    What I most struggle to understand is, when people state that there are several serious risks of bias, shortcomings in the trial methodology, limitations in applicability etc., but that isn't acknowledged in their conclusion. That seems to me to be the case in the assessment of PACE by Students...
  16. MSEsperanza

    Bias due to a lack of blinding: a discussion

    Moved from "A general thread on the PACE trial" Cant' assess at the moment if this warrants an own thread and anyway don't feel up to open one, so park some thoughts here: How to deal with the unwillingness of so many people that should know better to acknowledge the issue with subjective...
  17. MSEsperanza

    USA: Centers for Disease Control (CDC) - Post Covid Conditions: Interim Guidance, June 2021, updated June 2024

    Trial By Error: #MEAction’s Chronic Illness Survey; Patients’ Research Informs CDC’s Long-COVID Advice https://www.virology.ws/2021/06/15/trial-by-error-meactions-chronic-illness-survey-patients-research-informs-cdcs-long-covid-advice/#more-16069
  18. MSEsperanza

    Open The Chronic Illness Survey Adventure (Symptom Cluster Characterization in Complex Chronic Disease)

    Trial By Error: #MEAction’s Chronic Illness Survey; Patients’ Research Informs CDC’s Long-COVID Advice https://www.virology.ws/2021/06/15/trial-by-error-meactions-chronic-illness-survey-patients-research-informs-cdcs-long-covid-advice/#more-16069
  19. MSEsperanza

    Independent advisory group for the full update of the Cochrane review on exercise therapy and ME/CFS (2020), led by Hilda Bastian

    I'm afraid that this could be an argument that actually doesn't apply. I think mis- / over-interpretation of the evidence base derived from biomedical research made it and continues to make it easy for the proponents of a BPS pathology model to dismiss some of the criticism they receive. It...
  20. MSEsperanza

    Article: Is Cognitive Behavioral Therapy the Gold Standard for Psychotherapy? 2017

    I missed that and his name is new to me. Does anyone have a link to provide some info about his support for CBT-GET?
Back
Top Bottom